Come and join us across the globe
Sign In

Impact of the RESILIENT-Extend Trial outcomes on stroke treatment in Brazil

Last update on March 18, 2025

The RESILIENT-Extend trial is the first major study of thrombectomy in the late time window conducted outside first-world countries. Francisco Mont'alverne explains the trial's design and key findings. He discusses the impact of conducting this study in Latin America compared to first-world countries, highlighting the challenges and implications for stroke care in the region.

On the same subject
Come and join us across the globe